OB/GYN Clinical Alert
RSSArticles
-
More Promise from Olaparib in Recurrent Ovarian Cancer: The BRCA Cohort
Olaparib, a poly (ADP)-ribose polymerase (PARP) inhibitor, demonstrated substantial delay until progression when administered to women as a maintenance therapy with BRCA-mutant recurrent ovarian cancer. -
Reduced Fetal Movement, Uterine Arteries, and Stillbirth
A recent study has shown a link between abnormal uterine artery waveforms in the second trimester and reduced fetal movements later in pregnancy, as well as with stillbirth and small for gestational age. -
Tamoxifen and Breast Cancer Incidence Among Women with Inherited Mutations in BRCA1 and BRCA2
-
Important New Monkey Study from Tom Clarkson
-
Labor — To Wait or Not to Wait: To Push or Not to Push
-
Clinical Features and Risk of Recurrence among Patients with Vaginal Intraepithelial Neoplasia
-
Clinical Briefs in Primary Care
-
Special Feature: The Phantom hCG Phenomenon
-
Treatment of Vulvar Vestibulitis with Submucous Infiltrations of Methylprednisolone and Lidocaine
-
Special Feature: Enlightened Management of IUGR